"10.1371_journal.pone.0050289","plos one","2012-11-30T00:00:00Z","Florence Abravanel; Stéphanie Raymond; Elodie Pambrun; Maria Winnock; Philippe Bonnard; Philippe Sogni; Pascale Trimoulet; François Dabis; Dominique Salmon-Ceron; Jacques Izopet; ANRS CO13 HEPAVIH Study Group","INSERM, U1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France; CHU Toulouse Purpan, Laboratoire de Virologie, Institut Fédératif de Biologie de Purpan, France; INSERM, U897 and ISPED, Université Victor Segalen, Bordeaux, France; Service des Maladies Infectieuses et Tropicales, Hôpital Tenon, AP-HP, Paris, France; Unité dHépatologie, Hôpital Cochin, AP-HP, Paris, France; Université Paris Descartes, Paris, France; CHU Pellegrin, Laboratoire de virologie, Bordeaux, France; CNRS, UMR 5234, Microbiologie fondamentale et pathogénicité, Université Bordeaux Segalen, Bordeaux, France; Service des Maladies Infectieuses et Tropicales, Hôpital Cochin, AP-HP, Paris, France","¶ Membership of the ANRS CO13 HEPAVIH Study Group is provided in Appendix S1.","The ANRS CO13 HEPAVIH cohort is sponsored by Abbott France, Glaxo-Smith-Kline, Roche and Schering-Plough, and INSERMs Programme cohortes TGIR. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","11","Florence Abravanel","FA",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
